Conning Inc. Trims Stake in HCA Healthcare, Inc. $HCA

Conning Inc. trimmed its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 5.0% during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 1,169 shares of the company’s stock after selling 62 shares during the quarter. Conning Inc.’s holdings in HCA Healthcare were worth $448,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also made changes to their positions in HCA. PDS Planning Inc grew its holdings in shares of HCA Healthcare by 12.9% in the second quarter. PDS Planning Inc now owns 1,260 shares of the company’s stock worth $483,000 after purchasing an additional 144 shares during the last quarter. Monument Capital Management purchased a new position in shares of HCA Healthcare during the second quarter worth approximately $234,000. Cyndeo Wealth Partners LLC purchased a new stake in shares of HCA Healthcare in the second quarter valued at approximately $9,376,000. Galvin Gaustad & Stein LLC raised its position in HCA Healthcare by 7.4% during the 2nd quarter. Galvin Gaustad & Stein LLC now owns 83,921 shares of the company’s stock valued at $32,150,000 after purchasing an additional 5,814 shares in the last quarter. Finally, 3Chopt Investment Partners LLC grew its position in shares of HCA Healthcare by 9.2% during the 2nd quarter. 3Chopt Investment Partners LLC now owns 1,043 shares of the company’s stock worth $400,000 after buying an additional 88 shares in the last quarter. 62.73% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In related news, EVP Michael S. Cuffe sold 3,836 shares of the firm’s stock in a transaction dated Monday, September 8th. The stock was sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the sale, the executive vice president directly owned 31,503 shares of the company’s stock, valued at $13,194,716.52. This trade represents a 10.85% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 1.30% of the stock is currently owned by company insiders.

Analyst Ratings Changes

A number of research firms recently weighed in on HCA. Wolfe Research lowered shares of HCA Healthcare from an “outperform” rating to a “peer perform” rating in a research note on Monday, July 28th. Barclays lifted their price target on HCA Healthcare from $390.00 to $445.00 and gave the company an “overweight” rating in a report on Thursday, September 18th. UBS Group set a $465.00 target price on HCA Healthcare in a research note on Wednesday. Morgan Stanley lowered their price target on shares of HCA Healthcare from $410.00 to $400.00 and set an “equal weight” rating on the stock in a report on Monday, July 28th. Finally, Royal Bank Of Canada decreased their target price on shares of HCA Healthcare from $404.00 to $401.00 and set an “outperform” rating for the company in a research report on Monday, July 28th. One research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and nine have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $422.31.

HCA Healthcare Trading Down 1.0%

NYSE HCA opened at $414.73 on Friday. The stock has a market cap of $97.04 billion, a P/E ratio of 17.43, a P/E/G ratio of 1.31 and a beta of 1.40. HCA Healthcare, Inc. has a 12-month low of $289.98 and a 12-month high of $439.01. The company has a fifty day simple moving average of $405.12 and a two-hundred day simple moving average of $375.85.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings results on Friday, July 25th. The company reported $6.84 earnings per share for the quarter, beating the consensus estimate of $6.20 by $0.64. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The business had revenue of $18.61 billion for the quarter, compared to the consensus estimate of $18.49 billion. During the same quarter in the previous year, the business earned $5.50 EPS. The company’s quarterly revenue was up 6.4% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. As a group, sell-side analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 30th. Shareholders of record on Tuesday, September 16th were paid a dividend of $0.72 per share. The ex-dividend date was Tuesday, September 16th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.7%. HCA Healthcare’s dividend payout ratio (DPR) is presently 12.11%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.